CA2322053A1 - Nouveaux nucleosides - Google Patents

Nouveaux nucleosides Download PDF

Info

Publication number
CA2322053A1
CA2322053A1 CA002322053A CA2322053A CA2322053A1 CA 2322053 A1 CA2322053 A1 CA 2322053A1 CA 002322053 A CA002322053 A CA 002322053A CA 2322053 A CA2322053 A CA 2322053A CA 2322053 A1 CA2322053 A1 CA 2322053A1
Authority
CA
Canada
Prior art keywords
nucleosides
cells
compounds
formula
term
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002322053A
Other languages
English (en)
Inventor
Devron Averett
Kandasamy Ramasamy
Robert Tam
Guangyi Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant Pharmaceuticals International Inc USA
Original Assignee
Icn Pharmaceuticals, Inc.
Devron Averett
Kandasamy Ramasamy
Robert Tam
Guangyi Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals, Inc., Devron Averett, Kandasamy Ramasamy, Robert Tam, Guangyi Wang filed Critical Icn Pharmaceuticals, Inc.
Priority claimed from CA002278158A external-priority patent/CA2278158A1/fr
Publication of CA2322053A1 publication Critical patent/CA2322053A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002322053A 1996-10-16 1998-01-13 Nouveaux nucleosides Abandoned CA2322053A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US2858696P 1996-10-16 1996-10-16
US60/028,586 1996-10-16
US60/036,094 1997-01-14
US3609497P 1997-01-17 1997-01-17
US4397497P 1997-04-23 1997-04-23
US60/043,974 1997-04-23
US5548797P 1997-08-12 1997-08-12
US60/055,487 1997-08-12
CA002278158A CA2278158A1 (fr) 1997-01-14 1998-01-13 Traitements lies a la cytokine destines a des affections

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002278158A Division CA2278158A1 (fr) 1996-10-16 1998-01-13 Traitements lies a la cytokine destines a des affections

Publications (1)

Publication Number Publication Date
CA2322053A1 true CA2322053A1 (fr) 1998-07-16

Family

ID=27508685

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002322053A Abandoned CA2322053A1 (fr) 1996-10-16 1998-01-13 Nouveaux nucleosides

Country Status (1)

Country Link
CA (1) CA2322053A1 (fr)

Similar Documents

Publication Publication Date Title
US6455508B1 (en) Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
US6455690B1 (en) L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
US6495677B1 (en) Nucleoside compounds
US6509320B1 (en) Purine L-nucleosides, analogs and uses thereof
EP0961775B1 (fr) Analogues de nucleosides l purine et leurs utilisations
US6423695B1 (en) Cytokine related treatments of disease
AU736075B2 (en) Cytokine related treatments of disease
US7056895B2 (en) Tirazole nucleoside analogs and methods for using same
US20090176721A1 (en) Nucleoside analogs with carboxamidine modified monocyclic base
EP1132393B1 (fr) L-Ribavirine et son utilisation
AU743366B2 (en) Novel nucleosides
EP1072607A2 (fr) Analogues de nucléosides-L-purine et leurs utilisations
EP1103559A1 (fr) Nucléosides auto-immunes
CA2322053A1 (fr) Nouveaux nucleosides
NZ505531A (en) 7-Propyl-8-oxo-alpha or beta-L-guanine alpha or beta-L-nucleoside
EP1277759A1 (fr) Traitements liés à la cytokine destinés à des affections
HRP20000423A2 (en) Novel nucleosides
AU751742B2 (en) Purine L-nucleosides, analogs and uses thereof
MXPA99006418A (es) Tratamiento de enfermedad ralacionados concitosina
HRP20000421A2 (en) Cytokine related treatments of disease
NZ505553A (en) 8-substituted alpha or beta L-guanosine analogs and uses thereof
HRP980477A2 (en) Cytokine related treatments of disease
CA2323791A1 (fr) Analogues de nucleosides l purine et leurs utilisations
NZ505554A (en) 8-substituted alpha or beta L guanosine analogs and derivatives useful for modulating Th1 and Th2 activities in a patient

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead